Current Advances in Closed Loop Stimulation

Dr. Cory Hunter, President of NANS, presents an in-depth overview of closed-loop spinal cord stimulation (SCS) and the breakthrough potential of ECAP-controlled therapy. He contrasts traditional open-loop systems with real-time, adaptive stimulation that adjusts automatically to patient movement and physiology. Dr. Hunter highlights the EVOKE study’s durable, long-term results and explains how ECAPs may serve as predictive biomarkers, allowing for trial-less implantation and objective pain assessment. He emphasizes the clinical implications for improving outcomes, reducing trial failure, and enhancing patient trust. This presentation signals a new era in neuromodulation and the emerging role of “electroceuticals” in pain medicine.